New PMA (Pre-market Approval) requirement for three devices
This article was originally published in Clinica
Executive Summary
Manufacturers of three medical devices have been put on alert that they must soon file a premarket approval application with the FDA if they want to continue marketing their products. The products are: indwelling blood oxyhaemoglobin concentration analysers, a photo electric device used to measure the oxygen carrying capacity of haemoglobin in blood; cardiopulmonary bypass pulsatile flow generators, an electrically and pneumatically-operated device placed in a cardiopulmonary bypass circuit to create pulsatile blood flow; and the ocular plethysmograph, a device that diagnoses occluded carotid arteries by measuring whether pulsations of the artery produce volume changes in the eye.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.